Tissue Regenix Share Discussion Threads

[cerrito] 20/6/2025 17:46:36

Seems to have been an active trading day by TRX standards today which no doubt explains the late price fall.
People spooked by lack of news about annual results so close to 6 month cut off? Or something more specific? Hopefully news on Monday.

[tnt99] 10/6/2025 07:41:01

Maybe a takeover is imminent and an important licence was gained by the buyer?

[p1nkfish] 09/6/2025 19:48:01

If they raise it may be along the lines of CRX a while back with Griffiths, Mills and Sneller. I took part and was well rewarded overall and final outcome was a sale to Evotec in Germany.

[cerrito] 09/6/2025 19:25:20

I had rather forgotten about them and the RNS this morning reminded me and I did a v modest top up.
I rechecked the quality of the Board and on paper they are v good. I was impressed by Glenn when he was at Consort. I need to say that I am abit perplexed that he did not sign off on the April 8th RNS on the ending of the strategic review as this is his job rather than the CEO.
I am not comfortable with the continued delay in getting the 2024 finals out- I see in the last 2 years they were out mid March which is what I would expect. One possible reason could be that they are having an issue with the auditors on the Going Concern statement and need to conclude a financing deal…but do not see this as being an issue here. I hope it is not due to issues unscrambling GBM V.
I can understand why Mr Mills is getting impatient..if he is..and I am sure that Messrs Sneller and Griffiths may be as well.
In some ways I can understand why they did not get much interest. Too small for established players..too small for people wanting to get into this competitive market and our friends in PE less gungho than before.

[p1nkfish] 09/6/2025 07:32:32

TU soon and good to see MDR announced today. Take with a pinch of salt but I do think this is close to the mark.

"With EU MDR approval, OrthoPure® XT can unlock:

A US $125–240 million direct market in European ACL reconstruction within a few years.

Supportive global niche (~US $30–;50 million) from the ACL graft market.

A stepping stone into broader knee biologics and multi‑ligament procedures in a US $2–4 billion+ opportunity across Europe.

These estimates align well with Tissue Regenix’s 2024-2030 strategic pillar to scale dCELL® products across EU and outside EU markets."

I suspect no sale of the company went through because of the price tag. TRX wouldn't sell themselves cheap given the potential. Some future time they will be acquired imho for a decent price compared to today - many multiples imho. Dyor etc as this may be totally wrong, just my thoughts.

[arthur_lame_stocks] 05/6/2025 10:17:18

I bought some today. A bit risky considering growth stalled badly in the second half but the company seems to believe it can return to growth and Chris Mills wants to sell.

Whatever happens the shares are not worthless.

[p1nkfish] 01/6/2025 09:55:10

Something towards 65.59% is in 3%+ holders and Directors.
The number of shares floating about is around 24.6M outside of those.

Peanuts in value but massive compared to average daily volume (30.5K approx over past 3 months). Some decent TU or transformational event/news needed else remains bombed-out and ignored.

[p1nkfish] 30/5/2025 12:33:08

I think probably re-iteration of previous guidance. It says it all unless some major news.

[dylanl2] 30/5/2025 12:08:31

Next news is early June do we think?

[mickhay3] 30/5/2025 09:28:16

The whole of the health sector has been down or flat for last 3 years.United health group is the 2nd biggest company on the dow and are about 50% down. Link to United health group chart below
https://ibb.co/JR5qGF6P

[arthur_lame_stocks] 15/5/2025 12:36:01

It looks to me like growth stalled in the second half.

[tnt99] 02/5/2025 12:37:57

Or taking them a long time to count the money lol

[p1nkfish] 02/5/2025 12:10:03

Or problems.

[tnt99] 02/5/2025 11:56:36

Possible bid maybe

[tnt99] 02/5/2025 11:56:15

Results must be being held back why?

[tnt99] 30/4/2025 17:21:08

Where are the annual results?

[tnt99] 24/4/2025 08:02:23

Why the weakness this company is profitable and growing must be a takeover target for a larger companyTo take control

[onesock] 16/4/2025 14:01:09

Hopefully it can navigate them through production in both US and UK. I recall some of their products being assessed for approval to be licensed in China, for example, which UK production could perhaps meet.

[tnt99] 15/4/2025 19:54:42

Will tissue regenix be effected by trump tarrifs even though it has a USA premises

[tnt99] 08/4/2025 11:53:19

Back up to 60p I hope at least!!

[hedgehog 100] 08/4/2025 11:11:29

08/04/2025 07:00 RNS Regulatory News Tissue Regenix Group PLC Conclusion of Strategic Review & Offer Period LSE:TRX Tissue Regenix Group Plc

"... The Board believes the Company's valuation is now at a level which bears no resemblance to the prospects or the typical valuation that a business in this sector would be ascribed; the Board believes that despite varying degrees of interest in the Company, the current equity value cannot be used as a base from which a strategic transaction can occur. The Board, in conjunction with advisors and major shareholders, will continue to assess the best route forward to deliver the substantial value that exists in this business, which is not being reflected in the share price today.

The Board has determined that based on discussions to date, it does not believe there is a prospect of an appropriate offer for the issued, and to be issued, share capital of Tissue Regenix being forthcoming in the near term. Accordingly, the Company is no longer in discussions with any interested parties. ..."




The company is in effect saying that its AIM listing is scuppering any chance of a strategic transaction at a decent price, which is what they seem to want, to deliver greater value.

The logical conclusion from this therefore would be to delist, like so many other shares are doing at the moment.

So I think there's an odds-on possibility that this will happen, in the not too distant future.

[nchanning] 08/4/2025 07:41:25

Could be interesting here after a big fall , only concern here is are the big shareholders planning to take this private ?